{"id":"W3083502363","doi":"10.1038/s41408-020-00357-4","title":"Elotuzumab, lenalidomide, and dexamethasone in RRMM: final overall survival results from the phase 3 randomized ELOQUENT-2 study","year":2020,"lang":"en","type":"article","venue":"Blood Cancer Journal","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":153,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Alberta; Queen Elizabeth II Health Sciences Centre; Princess Margaret Cancer Centre; Dalhousie University","funders":"AbbVie Biotherapeutics; Bristol-Myers Squibb","keywords":"Lenalidomide; Medicine; Dexamethasone; Internal medicine; Multiple myeloma; Regimen; Hazard ratio; Clinical endpoint; Oncology; Adverse effect; Randomized controlled trial; Confidence interval","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00445687,0.0008705715,0.001724717,0.0003009398,0.0002253508,0.0009060454,0.0007463568,0.0008743264,0.001784612],"category_scores_gemma":[0.001783464,0.0003260426,0.00234575,0.0003718731,0.0004595016,0.0006220171,0.0005200516,0.002129797,0.0003608347],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007437432,"about_ca_system_score_gemma":0.0008578198,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006082371,"about_ca_topic_score_gemma":0.002448866,"domain_scores_codex":[0.9985561,0.0009963628,0.00006886951,0.0001197956,0.0001353765,0.0001234805],"domain_scores_gemma":[0.9989238,0.0002743138,0.0003409817,0.0001048091,0.00006576101,0.0002903558],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.8928996,0.009372162,0.008754101,0.0006925625,0.003820844,0.00009481435,0.0001338459,0.001631512,0.007278913,0.0001857615,0.00299594,0.07213993],"study_design_scores_gemma":[0.7479631,0.1962538,0.04352309,0.0001369113,0.003242985,0.000259718,0.00007318861,0.001138895,0.001712096,0.0003708164,0.00527051,0.00005487599],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.985134,0.009807525,0.0004562255,0.0005764757,0.0001489275,0.0008837587,0.001558768,0.00007375666,0.001360656],"genre_scores_gemma":[0.9885467,0.003242636,0.001265866,0.001277427,0.0002642522,0.001099662,0.00308621,0.00003304554,0.001184244],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.00445687,"threshold_uncertainty_score":0.02357042,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1002394415893604,"score_gpt":0.3762224000222738,"score_spread":0.2759829584329133,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}